Cargando…
Mediterranean fever gene variants modify clinical phenotypes of idiopathic multi‐centric Castleman disease
Four cases of idiopathic multi‐centric Castleman disease (iMCD) reportedly have variants in hereditary autoinflammatory disease‐related genes; however, the frequency and role of these variants in iMCD is still unknown. We therefore investigated such gene variants among patients with iMCD and aimed t...
Autores principales: | Endo, Yushiro, Koga, Tomohiro, Ubara, Yoshihumi, Sumiyoshi, Remi, Furukawa, Kaori, Kawakami, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663796/ https://www.ncbi.nlm.nih.gov/pubmed/34096620 http://dx.doi.org/10.1111/cei.13632 |
Ejemplares similares
-
Candidate biomarkers for idiopathic multicentric Castleman disease
por: Sumiyoshi, Remi, et al.
Publicado: (2022) -
Rheumatoid arthritis-like active synovitis with T-cell activation in a case of idiopathic multicentric Castleman disease: A case report
por: Otsuka, Mizuna, et al.
Publicado: (2019) -
Granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-α in combination is a useful diagnostic biomarker to distinguish familial Mediterranean fever from sepsis
por: Koga, Tomohiro, et al.
Publicado: (2021) -
Randomized, double-blind, placebo-controlled, parallel-group trial of sirolimus for tocilizumab-resistant idiopathic multicentric Castleman disease: Study protocol for clinical trial
por: Koga, Tomohiro, et al.
Publicado: (2020) -
An open-label continuation trial of sirolimus for tocilizumab-refractory idiopathic multicentric Castleman disease: Study protocol for an investigator-initiated, multicenter, open-label trial (SPIRIT compliant)
por: Koga, Tomohiro, et al.
Publicado: (2020)